Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo ...

Krystal Biotech Inc. KRYS on Thursday released a clinical update for its intratumoral immunotherapy, KB113. The treatment ...

Unsecured, non-interest-bearing loan provides additional working capital supportWINNIPEG, Manitoba, Oct. 16, 2026 (GLOBE NEWSWIRE) -- (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a ...

Gilead Sciences partnered with Vir Biotechnology on Wednesday to discover and develop three drugs aimed at solid tumors. ・AstraZeneca signed an up-to-$1.5 billion AI collaboration with insitro for ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Frazier Life Sciences also hit the Nasdaq on Friday with its second biotech-focused special purpose acquisition company (SPAC ...

Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline ...

Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma ...

While industry leaders are unsure whether the U.S. or China will prevail, they are largely united in the belief that Europe ...

The list of departing ASX biotech CEOs continues to swell, with Medical Developments chief Brent MacGregor signing off today.